JPM25, Day 1: GSK's billion-dollar bet, Bayer's trial first, Lilly buys Scorpion, and more
Fecha de publicación:
09/01/2025
Fuente: FierceBiotech
It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the year.